IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pasithea Therapeutics Corp

CUSIP: 70261F103 | 28 institutional holders

Quarters

Q3 2026Q4 2025Q4 2023Q3 2023Q2 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Hurley Capital, LLC21,000
0.0% of portfolio›$10.4K
StyleTurnoverLocationFiled
Hurley Capital, LLC
21,000$10.4K0.0%ETFLowNew York, NY2026-11-05